TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Adesso BioProducts AB
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 2,580,396 | 2,439,952 | 2,001,160 |
Financial expenses | 10,420 | 10,890 | 11,970 |
Earnings before taxes | 158,631 | 170,392 | 101,421 |
EBITDA | 170,121 | 182,691 | 115,392 |
Total assets | 853,676 | 801,246 | 575,219 |
Current assets | 836,862 | 783,822 | 556,413 |
Current liabilities | 307,012 | 359,260 | 237,160 |
Equity capital | 419,344 | 310,721 | 197,052 |
- share capital | 95 | 98 | 105 |
Employees (average) | 21 | 21 | 20 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 49.1% | 38.8% | 34.3% |
Turnover per employee | 122,876 | 116,188 | 100,058 |
Profit as a percentage of turnover | 6.1% | 7.0% | 5.1% |
Return on assets (ROA) | 19.8% | 22.6% | 19.7% |
Current ratio | 272.6% | 218.2% | 234.6% |
Return on equity (ROE) | 37.8% | 54.8% | 51.5% |
Change turnover | 213,774 | 577,054 | -112,535 |
Change turnover % | 9% | 31% | -5% |
Chg. No. of employees | 0 | 1 | 2 |
Chg. No. of employees % | 0% | 5% | 11% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.